All articles tagged with #biodefense
AI-enabled biotech advances are driving a convergence that could raise the risk of a lethal, human-made pathogen—accidentally or intentionally—even as some call for stronger guardrails and biodefense improvements; more labs and easier experimentation may increase the chance of mishaps, fueling debate over risk versus potential medical breakthroughs.
Emails show four NIAID staffers were ordered to remove the words “biodefense” and “pandemic preparedness” from the institute’s site, a move experts say could hamper future infectious-disease readiness amid a broader NIH reorganization and workforce cuts; the change signals a deprioritization of these traditional research pillars, potentially weakening the U.S. response to evolving pathogens.
Nature reports that the US National Institute of Allergy and Infectious Diseases will deprioritize biodefense and pandemic preparedness, scrubbing those terms from its pages as it shifts toward basic immunology and other domestic infectious-disease work. About a third of its $6.6 billion budget funds emerging infectious diseases and biodefense, and the move accompanies leadership changes and a review of grant portfolios, raising concerns about readiness for evolving pathogens.
The CDC has reversed over half of the 1,300 layoffs, saving key staff involved in disease response, but some biodefense analysts responsible for national security threats have still been laid off.
While the US Department of Health and Human Services has recently cut nearly half a billion dollars in mRNA vaccine research funding, the US military continues to support certain mRNA projects, particularly those targeting deadly pathogens like Crimean–Congo hemorrhagic fever, highlighting a divided approach to vaccine development amid political and policy challenges.
The Trump administration has canceled nearly $500 million in contracts for mRNA vaccine development, citing safety concerns and advocating for older vaccine technologies, a move criticized by public health experts who warn it could undermine pandemic preparedness and national security.
Health Secretary Robert F. Kennedy Jr. has canceled nearly $500 million in mRNA vaccine contracts, criticizing the technology and shifting focus to traditional vaccines, which has sparked concern among scientists about potential impacts on pandemic preparedness and national security.
The Pentagon's biodefense review highlights the urgent need for the US military to address the growing threat of bioweapons and catastrophic events, including pandemics. The review singles out China as the key long-term threat, expressing doubts about Beijing's compliance with international rules on biowarfare and raising concerns over its integration of civilian biological research programs into the military. The report also identifies Russia, North Korea, Iran, and violent extremist organizations as persistent threats. The review calls for a more coordinated and unified approach within the Defense Department to address the biosecurity threat, emphasizing the need for improved intelligence collection, biosurveillance, and early-warning analysis.